Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sabela Lens

Showing results (71-80 of 162) with videos related to

Pageof 17
Sort By:
Advances in Therapy|October 25, 2019
Efficacy and Safety of 8 Weeks of Glecaprevir/Pibrentasvir in Treatment-Naïve, HCV-Infected Patients with APRI ≤ 1 in a Single-Arm, Open-Label, Multicenter StudyRobert J Fontana, Sabela Lens, Stuart McPherson, et al.
Journal of Gastroenterology|September 8, 2019
Impact of sustained virological response with DAAs on gastroesophageal varices and Baveno criteria in HCV-cirrhotic patientsMarc Puigvehí, María-Carlota Londoño, Xavier Torras, et al.
Journal of Gastroenterology|September 27, 2012
Combinations of simple baseline variables accurately predict sustained virological response in patients with recurrent hepatitis C after liver transplantationGonzalo Crespo, José A Carrión, Mairene Coto-Llerena, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|December 22, 2019
Higher seroprevalence of hepatitis E virus in autoimmune hepatitis: Role of false-positive antibodiesLaura-Patricia Llovet, Jordi Gratacós-Ginés, Oswaldo Ortiz, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|October 7, 2020
Improvement of sexuality after hepatitis C cure with direct acting antiviralsZoe Mariño, Sergio Rodríguez-Tajes, Concepció Bartrés, et al.
Plos One|May 10, 2016
Metabolic Characterization of Advanced Liver Fibrosis in HCV Patients as Studied by Serum 1H-NMR SpectroscopyNieves Embade, Zoe Mariño, Tammo Diercks, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|April 28, 2015
Association Between Severe Portal Hypertension and Risk of Liver Decompensation in Patients With Hepatitis C, Regardless of Response to Antiviral TherapySabela Lens, Diego Rincón, Montserrat García-Retortillo, et al.
Journal of Hepatology|April 17, 2016
Unexpected high rate of early tumor recurrence in patients with HCV-related HCC undergoing interferon-free therapyMaría Reig, Zoe Mariño, Christie Perelló, et al.
Frontiers in Immunology|March 13, 2020
Cirrhosis Hampers Early and Rapid Normalization of Natural Killer Cell Phenotype and Function in Hepatitis C Patients Undergoing Interferon-Free TherapyElena Perpiñán, Sofía Pérez-Del-Pulgar, María-Carlota Londoño, et al.
Journal of Hepatology|October 5, 2014
The addition of a protease inhibitor increases the risk of infections in patients with hepatitis C-related cirrhosisMaria-Carlota Londoño, Christie Perelló, Joaquín Cabezas, et al.
Pageof 17

Showing results (71-80 of 162) with videos related to

Sort By:
Pageof 17
Advances in Therapy|October 25, 2019
Efficacy and Safety of 8 Weeks of Glecaprevir/Pibrentasvir in Treatment-Naïve, HCV-Infected Patients with APRI ≤ 1 in a Single-Arm, Open-Label, Multicenter StudyRobert J Fontana, Sabela Lens, Stuart McPherson, et al.
Journal of Gastroenterology|September 8, 2019
Impact of sustained virological response with DAAs on gastroesophageal varices and Baveno criteria in HCV-cirrhotic patientsMarc Puigvehí, María-Carlota Londoño, Xavier Torras, et al.
Journal of Gastroenterology|September 27, 2012
Combinations of simple baseline variables accurately predict sustained virological response in patients with recurrent hepatitis C after liver transplantationGonzalo Crespo, José A Carrión, Mairene Coto-Llerena, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|December 22, 2019
Higher seroprevalence of hepatitis E virus in autoimmune hepatitis: Role of false-positive antibodiesLaura-Patricia Llovet, Jordi Gratacós-Ginés, Oswaldo Ortiz, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|October 7, 2020
Improvement of sexuality after hepatitis C cure with direct acting antiviralsZoe Mariño, Sergio Rodríguez-Tajes, Concepció Bartrés, et al.
Plos One|May 10, 2016
Metabolic Characterization of Advanced Liver Fibrosis in HCV Patients as Studied by Serum 1H-NMR SpectroscopyNieves Embade, Zoe Mariño, Tammo Diercks, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|April 28, 2015
Association Between Severe Portal Hypertension and Risk of Liver Decompensation in Patients With Hepatitis C, Regardless of Response to Antiviral TherapySabela Lens, Diego Rincón, Montserrat García-Retortillo, et al.
Journal of Hepatology|April 17, 2016
Unexpected high rate of early tumor recurrence in patients with HCV-related HCC undergoing interferon-free therapyMaría Reig, Zoe Mariño, Christie Perelló, et al.
Frontiers in Immunology|March 13, 2020
Cirrhosis Hampers Early and Rapid Normalization of Natural Killer Cell Phenotype and Function in Hepatitis C Patients Undergoing Interferon-Free TherapyElena Perpiñán, Sofía Pérez-Del-Pulgar, María-Carlota Londoño, et al.
Journal of Hepatology|October 5, 2014
The addition of a protease inhibitor increases the risk of infections in patients with hepatitis C-related cirrhosisMaria-Carlota Londoño, Christie Perelló, Joaquín Cabezas, et al.
Pageof 17